TITLE

RESTRICTING PAIN MEDS FOR INJURED WORKERS CAN RESULT IN UNINTENDED MEDICAL COSTS

AUTHOR(S)
HARRISON, SHEENA
PUB. DATE
February 2015
SOURCE
Business Insurance;2/16/2015, Vol. 49 Issue 4, p0019
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the concerns raised by medical experts on the restriction of medications for injured workers suffering chronic pain in the U.S. Topics covered include the need for workers compensation insurers and payers to evaluate the cases of injured workers to determine appropriate treatments, the revision by the Federation of State Medical Boards of its policy on using opioids for chronic pain and the failure of the workers compensation industry to provide alternative therapies.
ACCESSION #
101094283

 

Related Articles

  • Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Vadivelu, Nalini; Kai, Alice; Maslin, Benjamin; Kodumudi, Gopal; Legler, Aron; Berger, Jack M. // Therapeutics & Clinical Risk Management;2015, Vol. 11, p95 

    Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have fewer gastrointestinal side effects...

  • Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? Kissin, Igor // Journal of Pain Research;2013, Vol. 6, p513 

    Background: For the past 30 years, opioids have been used to treat chronic nonmalignant pain. This study tests the following hypotheses: (1) there is no strong evidence-based foundation for the conclusion that long-term opioid treatment of chronic nonmalignant pain is effective; and (2) the main...

  • Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Devulder, J.; Jacobs, A.; Richarz, U.; Wiggett, H. // BJA: The British Journal of Anaesthesia;Oct2009, Vol. 103 Issue 4, p576 

    Background: There is little evidence that short-acting opioids as rescue medication for breakthrough pain is an optimal long-term treatment strategy in chronic non-malignant pain. We compared clinical studies of long-acting opioids that allowed short-acting opioid rescue medication with those...

  • Study reveals significant misuse of opioids among patients with pain.  // Reactions Weekly;9/5/2009, Issue 1268, p4 

    The article discusses a study on the misuse of opioid among patients with pain. Study authors administered 938,586 urine toxicology tests on more than 500,000 patients who were prescribed opioid analgesics for chronic pain management. They found that only 25 percent of patients had no evidence...

  • Versorgungslücke in der Akutschmerztherapie? Gehling, M.; Tryba, M. // Anaesthesist;Oct2013, Vol. 62 Issue 10, p785 

    No abstract available.

  • The cost of reducing pain associated with chronic wound management. Clark, Michael // British Journal of Community Nursing;Dec2007 Supplement, Vol. 12, p12 

    The significant financial costs associated with care of chronic wounds are commonly cited, but health economic analyses are often undermined by incomplete data and poor evidence of the effectiveness of interventions. This article highlights additional elements of cost associated with wounds that...

  • National Pain Strategy: Pain Management for All Australians.  // Issues;Mar2013, Issue 102, p34 

    The article presents information on the Australia National Pain Strategy. The project was a collaboration of health professionals, consumers and funders whose aim was to find an integrated approach to pain management in order to improve care for all pain sufferers in Australia, which costs the...

  • The Use of Opioid Analgesics for Chronic Pain: Minimizing the Risk for Harm. Argoff, Charles E; Viscusi, Eugene R // American Journal of Gastroenterology;Aug2014 Supplement, Vol. 109, p3 

    Chronic noncancer pain is common and consequential, affecting ∼100 million people in the United States alone and costing, when direct and indirect costs are combined, in excess of $635 billion. For certain individuals, opioids may be an effective option for the management of chronic pain;...

  • States turn to treatment guidelines. Ceniceros, Roberto // Business Insurance;11/4/2013, Vol. 47 Issue 22, p0044 

    The article discusses the Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain use for determining appropriate treatment for injured workers in Washington.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics